Publications

2009

Ritz E, Krum H, Schlaich M, Whitbourn R, Sobotka PA, Sadowski J, Bartus K, Kapelak B, Walton A, Sievert H, Thambar S, Abraham WT, Esler M, Wang Y, Tsun Z, Machnik A, Neuhofer W, Jantsch J, Dahlmann A, Tammela T, Machura K, Park JK, Beck FX, Müller DN, Derer W, Goss J, Ziomber A, Dietsch P, Wagner H, van Rooijen N, Kurtz A, Hilgers KF, Alitalo K, Eckardt KU, Luft FC, Kerjaschki D, Titze J. New approaches to pathogenesis and management of hypertension. Clin J Am Soc Nephrol 2009 Dec;4(12):1886-91.

Krum H.  Optimising management of chronic heart failure.  Lancet  2009 Nov 28;374(9704):1808-1809.  (invited editorial)

Zammit SC, Cox AJ, Gow RM, Zhang Y, Gilbert RE, Krum H, Kelly DJ, Williams SJ.  Evaluation and optimization of antifibrotic activity of cinnamoyl anthranilates. Bioorg Med Chem. 2009 Dec 15;19(24):7003-6.

Chan CC, Reid CM, Aw TJ, Liew D, Haas SJ, Krum H.  Do COX-2 inhibitors raise blood pressure more than nonselective NSAIDs and placebo?  An updated meta-analysis.  J Hypertens 2009;Dec 27(12):2332-2341. 

Thom O, Taylor DM, Wolfe RE, Cade J, Myles P, Krum H, Wolfe R. Comparison of a supra-sternal cardiac output monitor (USCOM) with the pulmonary artery catheter.  Br J Anaesth. 2009 Dec;103(6):800-4.

Kotecha D, Flather M, McGrady M, Pepper J, New G, Krum H, Eccleston D.  Contemporary predictors of coronary artery disease in patients referred for angiography.  Eur J Cardiovasc Prev Rehabil. 2009 Oct 24. [Epub ahead of print]

Schlaich MP, Sobotka PA, Krum H, Whitbourn R, Walton A, Esler MD.  Renal Denervation as a Therapeutic Approach for Hypertension: Novel Implications for an Old Concept.  Hypertension 2009 Dec;54(6):1195-1201.

Kemp W, Kompa A, Phrommintikul A, Herath C, Zhiyuan J, Angus P, McLean C, Roberts S, Krum H.  Urotensin II modulates hepatic fibrosis and portal hemodynamic alterations in rats.  Am J Physiol Gastrointest Liver Physiol. 2009 Oct;297(4):G762-7.

Weber MA, Black H, Bakris G, Krum H, Linas S, Weiss R, Linseman JV, Wiens BL, Warren MS, Lindholm LH.  A selective endothelin-receptor antagonist to reduce blood pressure in patients with treatment-resistant hypertension: a randomised, double-blind, placebo-controlled trial.   Lancet 2009 Oct 24;374(9699):1423-31.

Leet A, Richardson M, Senior JA, Funston R, Skiba M, Bailey M, Krum H.  A bioavailability study of cyclosporine: comparison of Neoral versus Cysporin in stable heart transplant recipients.  J Heart Lung Transplant. 2009 Sep;28(9):894-8.

Rasmussen HH, Figtree GA, Krum H, Bundgaard H.  The use of beta3-adrenergic receptor agonists in the treatment of heart failure.  Curr Opin Investig Drugs. 2009 Sep;10(9):955-62.

Schlaich MP, Sobotka PA, Krum H, Lambert E, Esler MD.  Renal sympathetic-nerve ablation for uncontrolled hypertension.  N Engl J Med. 2009 Aug 27;361(9):932-4. (letter)

Gheorghiade M, Khan S, Blair JE, Harinstein ME, Krum H, Mukherjee R, Pitt B; Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival (EPHESUS) Investigators.  The effects of eplerenone on length of stay and total days of heart failure hospitalization after myocardial infarction in patients with left ventricular systolic dysfunction.  Am Heart J. 2009 Sep;158(3):437-43.

Ezekowitz JA, Hernandez AF, Starling RC, Yancy CW, Massie B, Hill JA, Krum H, Diaz R, Ponikowski P, Metra M, Howlett JG, Gennevois D, O’Connor CM, Califf RM, Fonarow GC.  Standardizing care for acute decompensated heart failure in a large megatrial: The approach for the Acute Studies of Clinical Effectiveness of Nesiritide in Subjects with Decompensated Heart Failure (ASCEND-HF).  Am Heart J 2009;157:219-228.

Krum H.  Consider beta blockers for patients with heart failure.  BMJ 2009;338:1384-1385.

Krum H, Iyngkaran P, Lekawanvijit S.  Pharmacologic management of the cardiorenal syndrome in heart failure.  Current Heart Failure Reports 2009;6:105-111.

Krum H, Sanders P.  Expanding indications for pacing in chronic heart failure.  MJA 2009; 190;470-471. (invited editorial)

Martin JH, Connelly KA, Boyle A, Kompa A, Zhang Y, Kelly D, Gilbert RE, Krum H.  Effect of atorvastatin on cardiac remodelling and mortality in rats following hyperglycemia and myocardial infarction.  Int J Card 2009 April 21. [Epub ahead of print]

Connelly KA, Kelly DJ, Zhang Y, Prior DL, Advani A, Cox AJ, Thai K, Krum H, Gilbert RE.  Inhibition of protein kinase C-β by ruboxistaurin preserves cardiac function and reduces extracellular matrix production in diabetic cardiomyopathy.  Circ Heart Fail 2009;2:129-137.

Krum H, Swergold G, Curtis SP, Kaur A, Wang H, Smugar SS, Weir MR, Laine L, Brater DC, Cannon CP.  Factors associated with blood pressure changes in patients receiving diclofenac or etoricoxib: results from the MEDAL study.  J Hypertension 2009;27:886-893.

Krum H, Schlaich M, Whitbourn R, Sobotka PA, Sadowski J, Bartus K, Kapelak B,Walton A, Sievert H, Thambar S, Abraham WT, Esler M.  Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study.  Lancet 2009;373:1275-1281.

Krum H, Curtis SP, Kaur A, Wang H, Smugar SS, Weir MR, Laine L, Brater DC, Cannon CP.  Baseline factors associated with congestive heart failure in patients receiving etoricoxib or diclofenac: multivariate analysis of the MEDAL program.  Eur J Heart Fail 2009;Jun 11(6):542-50.

Becker MC, Wang TH, Wisniewski L, Wolski K, Libby P, Luscher TF, Borer JS, Mascette AM, Husni ME, Solomon DH, Graham DY, Yeomans ND, Krum H, Ruschitzka F, Lincoff AM, Nissen SE for the PRECISION Investigators.  Rationale, design, and governance of Prospective Randomized Evaluation of Celecoxib Integrated Safety versus Ibuprofen Or Naproxen (PRECISION), a cardiovascular end point trial of nonsteroidal anti-inflammatory agents in patients with arthritis.  Am Heart J 2009;157:606-12.

McGrady M, Krum H.  Screening: the new frontier in heart failure management.  Cardiovasc Ther. 2009;27(1):1-3.

Schneider H, Lam L, Lokuge A, Krum H, Naughton MT, Smit P, Bystrzycki A, Eccleston D, Federman J, Flannery G, Cameron P.  B-type natriuretic peptide testing, clinical outcomes, and health services use in emergency department patients with dyspnea.  Ann Intern Med 2009;150:365-371.

Krum H, Abraham WT. Heart failure. Lancet  2009;373:941-955. (invited review) 

Kemp W, Colman J, Thompson K, Madan A, Vincent M, Chin-Dusting J, Kompa A, Krum H, Roberts S.  Norfloxacin treatment for clinically significant portal hypertension: results of a randomized double-blind placebo-controlled crossover trial.  Liver International  2009;29(3):427-433.

Brady SR, de Courten B, Reid CM, Cicuttini FM, de Courten MP, Liew D.  The role of traditional cardiovascular risk factors among patients with rheumatoid arthritis. J Rheumatol. 2009 Jan;36(1):34-40.

Reid CM, Ajani AE, Eccleston D.  Why we need a national registry in interventional cardiology.  Med J Aust. 2009 Feb 2;190(3):162-3.

Joubert J, Reid C, Barton D, Cumming T, McLean A, Joubert L, Barlow J, Ames D, Davis S. Integrated care improves risk-factor modification after stroke: initial results of the Integrated Care for the Reduction of Secondary Stroke model.  J Neurol Neurosurg Psychiatry. 2009 Mar;80(3):279-84.

Reid C, Billah B, Dinh DT, Skillington PD, Smith JA, Yii M, Seevanayagam S, Pick A, Mohajeri M, Shardey GC. An Australian Risk Prediction Model for 30-day Mortality after Isolated Coronary Artery Bypass - the AusSCORE. J Thorac Cardiovasc Surg 2009; 138: 904-10.  

Yap CH, Yan BP, Akowuah E, Dinh DT, Smith JA, Shardey GC, Tatoulis J, Skillington PD, Newcomb A, Mohajeri M, Pick A, Seevanayagam S, Reid CM. Does prior percutaneous coronary intervention adversely affect early and mid-term survival after coronary artery surgery? JACC Cardiovasc Interv 2009; 8:758-64.

Owen AJ, Retegan C, Rockell M, Jennings G, Reid CM.  Inertia or inaction? Blood pressure management and cardiovascular risk in diabetes. Clin Exp Pharmacol Physiol. 2009 Jul;36(7):643-7.

Walls HL, Peeters A, Son PT, Quang NN, Hoai NT, Loi do D, Viet NL, Khai PG, Reid CM.  Prevalence of underweight, overweight and obesity in urban Hanoi, Vietnam.  Asia Pac J Clin Nutr. 2009;18(2):234-9.

Cowan BR, Young AA, Anderson C, Doughty RN, Krittayaphong R, Lonn E, Marwick TH, Reid CM, Sanderson JE, Schmieder RE, Teo K, Wadham AK, Worthley SG, Yu CM, Yusuf S, Jennings GL.  The cardiac MRI substudy to ongoing telmisartan alone and in combination with ramipril global endpoint trial/telmisartan randomized assessment study in ACE-intolerant subjects with cardiovascular disease: analysis protocol and baseline characteristics.  Clin Res Cardiol. 2009 Jul;98(7):421-33.

Cowan BR, Young AA, Anderson C, Doughty RN, Krittayaphong R, Lonn E, Marwick TH, Reid CM, Sanderson JE, Schmieder RE, Teo K, Wadham AK, Worthley SG, Yu CM, Yusuf S, Jennings GL; ONTARGET Investigators.  Left ventricular mass and volume with telmisartan, ramipril, or combination in patients with previous atherosclerotic events or with diabetes mellitus (from the ONgoing Telmisartan Alone and in Combination With Ramipril Global Endpoint Trial [ONTARGET]).  Am J Cardiol. 2009 Dec 1;104(11):1484-9.

Briggs AM, March L, Lassere M, Reid C, Henderson L, Murphy B, van den Haak R, Rischin A, Staples M, Buchbinder R.  Baseline Comorbidities in a Population-Based Cohort of Rheumatoid Arthritis Patients Receiving Biological Therapy: Data from the Australian Rheumatology Association Database.  Int J Rheumatol. 2009; Epub ahead of print.

Ademi Z, Liew D, Chew D, Conner G, Shiel L, Nelson M, Soman A, Steg G, Bhatt DL, Reid C; REACH registry investigators. Drug treatment and cost of cardiovascular disease in Australia. Cardiovasc Ther. 2009 Fall;27(3):164-72.

Brasacchio D, Dinh DT, Billah B, Shardey G, Reid CM on behalf of the Australian Society of Cardiac and Thoracic Surgeons Database Project Steering Committee.  Cardiac Surgery in Victorian Public Hospitals 2007-2008: Hospital Report. Quality and Safety Branch, Department of Human Services, Melbourne VIC 2009.

Brasacchio D, Dinh DT, Billah B, Shardey G, Reid CM on behalf of the Australian Society of Cardiac and Thoracic Surgeons Database Project Steering Committee.  Cardiac Surgery in Victorian Public Hospitals 2007-2008:  Report to the Public. Quality and Safety Branch, Department of Human Services, Melbourne VIC 2009.

Brasacchio D, Dinh DT, Billah B, Shardey G, Reid CM on behalf of the Australian Society of Cardiac and Thoracic Surgeons Database Project Steering Committee.  Cardiac Surgery in Australian Hospitals 2007-2008: National Report.  Melbourne VIC 2009.

Dinh DT, Di Giambattista K, Billah B, Shardey G, Reid CM on behalf of the Australian Society of Cardiac and Thoracic Surgeons Database Project Steering Committee.  Cardiac Surgery in NSW Public Hospitals 2007-2008: NSW Service Report.  Greater Metropolitan Clinical Taskforce, NSW Health, Melbourne VIC 2009.

Gurvitch R, Lefkovits J, Warren RJ, Duffy SJ, Clark DJ, Eccleston D, Yan BP, Reid C, Brennan A, Andrianopoulos N, Ajani AE. Clinical outcomes of drug eluting stent use in high risk patients with ST elevation Myocardial Infarction. Int J Cardiol 2009 (Epub ahead of print)

Lim H, Farouque O, Andrianopoulos N, Yan B, Lim C, Brennan A, Reid C, Freeman M, Charter K, Black A New G, Ajani A, Duffy S, Clark D. Survival of elderly patients undergoing percutaneous coronary intervention for acute myocardial infarction complicated by cardiogenic shock. Journal of American College of Cardiology Interventions 2009;2:146-152.

Freeman M, Clark D, Andrianopoulos N, Duffy S, Lim H, Brennan A, Charter K, Shaw J, Horrigan M, Ajani A, Sebastain M, Reid C, Farouque O. Procedural and clinical outcomes of percutaneous coronary intervention for ostial lesions in proximal coronary arteries. Catheterization and Cardiovascular Intervention 2009;73:763-768.

Butler MJ, Eccleston D, Ajani A, Lefkovits J, Clark DJ, Andrianopoulos N, Brennan A, Reid CM, Farrington C, Walton AS, Dart AM, Duffy SJ, on behalf of the Melbourne Interventional Group (MIG). The effect of intended duration of clopidogrel use on early and late mortality and major adverse cardiac events in patients with drug-eluting stents.  American Heart Journal. 2009;157(5):899-907.

Yap C-H, Andrianopoulos N, Dinh DT, Billah B, Rosalion AM, Reid CM.  Short and mid-term outcomes of coronary artery bypass surgery performed by surgeons in training. The Journal of Thoracic and Cardiovascular Surgery. 2009;137:1088-1092.

Yan BP, Clark DJ, Buxton B, Ajani AE, Smith JA, Duffy SJ, Shardey GC, Skillington PD, Farouque O, Yii M, Yap C-H, Andrianopoulos N, Brennan A, Dinh D, Reid CM, on behalf of the Australasian Society of Cardiac and Thoracic Surgeons (ASCTS) and the Melbourne Interventional Group (MIG).  Clinical characteristics and early mortality of patients undergoing coronary artery bypass grafting compared to percutaneous coronary intervention: Insights from the Australasian Society of Cardiac and Thoracic Surgeons (ASCTS) and the Melbourne Interventional Group (MIG) registries. Heart Lung and Circulation. 2009;18(3):184-90.

Zwahlen D, Andrianopoulos N, Matheson B, Duchesne G, Millar J. High-Dose-Rate brachytherapy in combination with conformal external beam radiotherapy in the treatment of prostate cancer.  Brachytherapy.  2009;9(1):27-35.

Yap CH, Sposato L, Akowuah E, Theodore S, Dinh DT, Shardey GC, Skillington PD, Tatoulis J, Yii M, Smith JA, Mohajeri M, Pick A, Seevanayagam S, Reid CM. Contemporary results show repeat coronary artery bypass grafting remains a risk factor for operative mortality. Ann Thorac Surg 2009; 87(5): 1386-91.

Piercy M, McNicol L, Dinh DT, Story DA, Smith JA. Major complications related to the use of transesophageal echocardiography in cardiac surgery. J Cardiothorac Vasc Anesth 2009; 23(1): 62-5.

Soderberg S, Colquhoun D, Keech A, Yallop J, Barnes E, Pollicino C, Simes RJ, Tonkin A, Nestel P, for the LIPID Study Investigators.  Leptin but not adiponectin is a predictor of recurrent cardiovascular events in men: results from the Long-term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study.  Int J Obes 2009;33:123-30.

Barr EL, Boyko EJ, Zimmet PZ, Wolfe R, Tonkin AM, Shaw JE. Continuous relationships between non-diabetic hyperglycaemia and cardiovascular disease and all-cause mortality: the AusDiab Study. Diabetologia 2009;52:415-424.

Tonkin A, Forbes A, Haas SJ. The evidence on trial: Cholesterol lowering and cancer. Heart Asia 2009;1:6-10.

Barr EL, Tonkin AM, Welborn TA, Shaw JE. Validity of self-reported cardiovascular disease events in comparison to medical record adjudication and a statewide hospital morbidity database: the AusDiab study. Int Med J 2009;39:49-53.

Tonkin AM, Chen L. Where on the Healthcare continuum should we invest? The case for primary care? Heart Lung and Circ 2009;18:108-113.

Tonkin AM, Boyden AN, Colagiuri S. Maximising the effectiveness and cost-effectiveness of cardiovascular disease prevention in the general population. Med J Aust 2009;191:300-302.  

Cameron AJ, Dunstan DW, Owen N, Zimmet PZ, Barr ELM, Tonkin AM, Magliano D, Murray SG, Welborn TA, Shaw JE. Health and mortality consequences of abdominal obesity: evidence from the AusDiab study. Med J Aust 2009;191:202-208.  

Tonkin AM, Beauchamp A, Stevenson CN. The importance of extinguishing secondhand smoke. Circulation 2009;120:1339-1341.

Cui J, Forbes A, Kirby A, Simes J, Tonkin A. Laboratory and non-laboratory based risk prediction models for secondary prevention of cardiovascular disease: the LIPID study. Eur J Cardiovasc Prev Rehabil 2009;16:660-668.  

Driscoll A, Worrall-Carter L, Hare DL, Davidson PM, Riegel B, Tonkin A, Stewart S. Evidence-based chronic heart failure management programs: reality or myth? Qual Saf Health Care 2009; 18: 450-5.

Ashton E, Windebank E, Skiba M, Reid C, Schneider H, Rosenfeldt F, Tonkin A, Krum H. Why did high-dose rosuvastatin not improve cardiac remodeling in chronic heart failure? Mechanistic insights from the UNIVERSE study. Int J Cardiol (in press).

Stewart JI, Washbrook E, Tonkin A. Cardiovascular risk management. Moderate- to low-risk patients – management recommendations. Eur J Gen Practice (in press).

Chen L, Tonkin AM, Moon L, Mitchell P, Dobson A, Giles G, Hobbs M, Phillips P, Shaw JE, Simmons D, Simons LA, Fitzgerald AP, De Backer G, De Bacquer D. Recalibration and validation of the SCORE risk chart in the Australian population: the AusSCORE chart. Eur J Cardiovasc Prev Rehab (in press, accepted April 2009).

Beauchamp A, Peeters A, Wolfe R, Turrell G, Harriss L, Giles GG, English DR, McNeil J, Magliano D, Harrap S, Liew D, Hunt D, Tonkin AM. Inequalities in cardiovascular disease mortality: the role of behavioural, physiological and social risk factors. J. Epidemiology and Community Health (in press).

Chen L, Magliano DJ, Balkau B, Colagiuri S, Zimmet PZ, Tonkin AM, Shaw JE. An Australian diabetes risk assessment tool based on demographic, lifestyle and simple anthropometric measures. Med J Aust  (in press).

Barr EL, Cameron AJ, Balkau B, Zimmet PZ, Welborn T, Tonkin AM, Shaw JE. HOMA insulin sensitivity index, hyperglycaemia and the risk of all-cause mortality and cardiovascular disease in the general population – the AusDiab study. Diabetologia (in press).

Dennekamp M, Akram M, Abramson MJ, Tonkin AM, Sim MR, Fridman M, Erbas B. The role of outdoor air pollution as a trigger for an out-of-hospital cardiac arrests. Epidemiology (in press).

Cameron AJ, Sicree RA, Zimmet PZ, Albert KGMM, Tonkin AM, Balkau B, Tuomilhto J, Chitson P, Shaw JE. Cutpoints for abnormal waist circumference in Europids and South Asians: An evaluation of methods and re-assessment of association with incident type 2 diabetes. Obesity (in press).

Rostambeigi N, Tonkin A, Atkins R, Ghanbarian A, Cameron A, Forbes A, Momenan AA, Hadaegh F, Mirmiran P, Zimmet P, Azizi F, Shaw J. Waist circumference has heterogenous impact on the metabolic syndrome related outcomes in different ethnicities. Diabetes Res Clin Prac (in press). 

Kritharides L, Brown A, Jeremy R, Tonkin A, Walsh W, White H. Overview and determinants of CV disease in Indigenous populations. Heart Lung and Circulation (in press).

Curtis AJ, Stoelwinder JU, McNeil JJ. Management of waiting lists needs sound data. Med J Australia  2009;191(8):423-424. 

Evans SM, Cameron PA, McNeil JJ. Reforming NSW Health: the importance of using credible data. Med J Aust 2009;190(9):515.

Gabbe BJ, Bailey M, Cook JL, Makdissi M, Scase E, Ames N, Wood T, McNeil JJ, Orchard JW. The association between hip and groin injuries in the elite junior football years and injuries sustained during elite senior competition. Br J Sports Med 2009; [Epub ahead of print].

Haller G, Stoelwinder J, Myles P, McNeil JJ: Quality and Safety indicators in Anesthesia: Anesthesiology 2009;110(5):1158-1175.

Lowthian JA, Diug BO, Evans SM, Maxwell EL, Street AM, Piterman L, McNeil JJ. Who is responsible for the care of patients treated with warfarin therapy? Med J Aust 2009;190(12):674-677.

Ngo DT, Sverdlov AL, McNeil JJ, Horowitz JD. Correlates of arterial stiffness in an ageing population: role of asymmetric dimethylarginine. Pharmacol Res. 2009;60(6):503-507.

Ngo DT, Sverdlov AL, Willoughby SR, Nightingale AK Chirkov YY, McNeil JJ, Horowitz JD. Determinants of occurrence of aortic sclerosis in an aging population. JACC Cardiovasc Imaging 2009;2(8):919-927.

Nichol AD, Cooper DJ. POLAR Study Investigators on behalf of the ANZICS-Clinical Trials Group; EPO Study Investigators on behalf of the ANZICS-Clinical Trials Group. Can we improve neurological outcomes in severe traumatic brain injury? Something old (early prophylactic hypothermia) and something new (erythropoietin). Injury 2009;40(5):471-478.

Polizzotto MN, Phillips LE, Cannell P, Cohney S, Davies C, Opat SS, McNeil JJ, Wood EM. The Thrombotic thrombocytopenic purpura registry: a new national resource to inform patient care and medical research. Internal Medicine Journal 2009;39(1):72-73.

Ronaldson KJ, McNeil JJ. Improving drug safety by locating genetic markers for hypersensitivity reactions. Med J Aust 2009;190(11):641-643.

Thrift AG, Dewey HM, Sturm JW, Srikanth VK, Gilligan AK, Gall SL, Macdonnell RAL, McNeil JJ, Donnan GA. Incidence of Stroke Subtypes in the North East Melbourne Stroke Incidence Study (NEMESIS): Differences between Men and Women. Neuroepidemiology 2009;32(1):11-18.

Walls HL, McNeil JJ, Peeters A. Population Versus High-risk Interventions for Obesity. Epidemiology 2009;20(6):929-930.

Walls H, Wolfe R, Haby M, Magliano D, de Courten M, Reid C, McNeil JJ, Shaw, J. Trends in BMI of Urban Australian Adults, 1980-2000. Public Health Nutr. 2009;22:1-8 (Epub ahead of print).

Myles PS. What's new in trial design: propensity scores, equivalence, and non-inferiority. J Extra Corpor Technol. 2009 Dec;41(4):P6-10.

Leslie K, Myles PS, Forbes A, Chan MT. The Effect of Bispectral Index Monitoring on Long-Term Survival in the B-Aware Trial. Anesth Analg. 2009 Nov 12 (Epub ahead of print).

Leslie K, Chan MT, Myles PS, Forbes A, McCulloch TJ. Posttraumatic Stress Disorder in Aware Patients from the B-Aware Trial. Anesth Analg. 2009 Oct 27 (Epub ahead of print).

Haller G, Myles PS, Taffé P, Perneger TV, Wu CL. Rate of undesirable events at beginning of academic year: retrospective cohort study. BMJ. 2009 Oct 13;339:b3974.

Story DA, Fink M, Leslie K, Myles PS, Yap SJ, Beavis V, Kerridge RK, McNicol PL. Perioperative mortality risk score using pre- and postoperative risk factors in older patients. Anaesth Intensive Care. 2009 May;37(3):392-8.

Todd MM, Hindman BJ, Clarke WR, Torner JC, Weeks JB, Bayman EO, Shi Q, Spofford CM; IHAST Investigators. Perioperative fever and outcome in surgical patients with aneurysmal subarachnoid hemorrhage. Neurosurgery. 2009 May;64(5):897-908.

Haller G, Stoelwinder J, Myles PS, McNeil J. Quality and safety indicators in anesthesia: a systematic review. Anesthesiology. 2009 May;110(5):1158-75.  

Myles PS, Daly D, Silvers A, Cairo S. Prediction of neurological outcome using bispectral index monitoring in patients with severe ischemic-hypoxic brain injury undergoing emergency surgery. Anesthesiology. 2009 May;110(5):1106-15. 

Myles PR, Hubbard RB, McKeever TM, Pogson Z, Smith CJ, Gibson JE. Risk of community-acquired pneumonia and the use of statins, ace inhibitors and gastric acid suppressants: a population-based case-control study. Pharmacoepidemiol Drug Saf. 2009 Apr;18(4):269-75.

Buchanan FF, Myles PS, Cicuttini F. Patient sex and its influence on general anaesthesia. Anaesth Intensive Care. 2009 Mar;37(2):207-18. Review. PubMed PMID: 19400484. 

Myles PS. Bispectral index monitoring in ischemic-hypoxic brain injury. J Extra Corpor Technol. 2009 Mar;41(1):P15-9.  

Myles PS, Leslie K, Peyton P, Paech M, Forbes A, Chan MT, Sessler D, Devereaux PJ, Silbert BS, Jamrozik K, Beattie S, Badner N, Tomlinson J, Wallace S; ANZCA Trials Group. Nitrous oxide and perioperative cardiac morbidity (ENIGMA-II) Trial: rationale and design. Am Heart J. 2009 Mar;157(3):488-494.e1.

Silbert BS, Myles PS. Is fast-track cardiac anesthesia now the global standard of care? Anesth Analg. 2009 Mar;108(3):689-91.

Pasternak JJ, McGregor DG, Lanier WL, Schroeder DR, Rusy DA, Hindman B, Clarke W, Torner J, Todd MM; IHAST Investigators. Effect of nitrous oxide use on long-term neurologic and neuropsychological outcome in patients who received temporary proximal artery occlusion during cerebral aneurysm clipping surgery. Anesthesiology. 2009 Mar;110(3):563-73.

Daly DJ, Myles PS. Update on the role of paravertebral blocks for thoracic surgery: are they worth it? Curr Opin Anaesthesiol. 2009 Feb;22(1):38-43.

McIlroy DR, Myles PS, Phillips LE, Smith JA. Antifibrinolytics in cardiac surgical patients receiving aspirin: a systematic review and meta-analysis. Br J Anaesth. 2009 Feb;102(2):168-78.  

Wallace S, Myles P. 2009 Solving the challenges of large multicenter trials in Anesthesia. 26^th Aug HSR. PROCEEDINGS.

Leslie K, Myles PS, Forbes A, Chan MT. The Effect of Bispectral Index Monitoring on Long-Term Survival in the B-Aware Trial. Anesth Analg. 2009 Nov 12.

Leslie K, Chan MT, Myles PS, Forbes A, McCulloch TJ. Posttraumatic Stress Disorder in Aware Patients from the B-Aware Trial. Anesth Analg. 2009 Oct 27.

Myles PS, Leslie K, Peyton P, Paech M, Forbes A, Chan MT, Sessler D, Devereaux PJ, Silbert BS, Jamrozik K, Beattie S, Badner N, Tomlinson J, Wallace S. Nitrous oxide and perioperative cardiac morbidity (ENIGMA-II) Trial: rationale and design. ANZCA Trials Group. Am Heart J. 2009 Mar;157(3):488-494.e1.

Story DA, Fink M, Leslie K, Myles PS, Yap SJ, Beavis V, Kerridge RK, McNicol PL.  Perioperative mortality risk score using pre- and postoperative risk factors in older patients. Anaesth Intensive Care 2009 May;37(3):392-8.

Ramchandra R, Hood SG, Denton DA, Woods RL, McKinley MJ, McAllen RM, May CN. Basis for the preferential activation of cardiac sympathetic nerve activity in heart failure. Proceedings of the National Academy of Science USA 2009;106(3):924-928.

Woods RL, Tonkin AM, Nelson MR, Reid CM. Should aspirin be used for the primary prevention of cardiovascular disease in people with diabetes [editorial]? Medical Journal of Australia 2009;190:614-615.

Woods RL, Nelson MR, Tonkin AM, Reid CM. In reply: Should aspirin be used for the primary prevention of cardiovascular disease in people with diabetes [editorial]? Medical Journal of Australia 2009;191(6):356-357.

Driscoll A, Davidson P, Clark R, Huang N & Aho Z. on behalf of National Heart Foundation consumer resource working group. Tailoring Consumer Resources To Enhance Self-Care In Chronic Heart Failure. Australian Critical Care Journal 2009;22:133-140.

Cameron J, Worrall-Carter L, Driscoll A, & Stewart S.  Measuring self-care in chronic heart failure: a review of the psychometric properties of clinical instruments.  Journal of Cardiovascular Nursing 2009;24(6):10-22.

Clark RA, Driscoll A, Davidson PM.  Access and quality of Heart Failure Management Programs in Australia.  Australian Critical Care Journal 2009; 22:111-116.

Lee C, Riegel B, Driscoll A, Suwanno J, Moser DK,  Lennie TA, Dickson VV, Cameron J, Worrall-Carter L. Gender Differences in Heart Failure Self-Care: A Multinational Cross-Sectional Study. International Journal of Nursing Studies 2009;46:1485-1495.

Riegel B, Driscoll A, Suwanno J, Moser D, Dickson VV, Carlson B, Cameron J.  An International Perspective on Heart Failure Self-Care. Journal of Cardiac Failure 2009;15(6):508-516. 

BOOKS 

Tonkin A (ed.).Therapeutic Strategies in Lipid Disorders. Clinical Publishing, Oxford, 2009 

BOOK CHAPTERS

Haas SJ, Thien F, Tonkin AM, Kong DCM, Nelson MR, Demos L, Zimmet H, Krum H, Liew D, McNeil JJ. Clozapine-associated myocarditis and cardiomyopathy – It’s the heart that is important, not the classification. In: P.H. Bruno and M.T. Giordano (editors). Cardiomyopathies: Effects, Causes and Treatments; Nova Science Publishers, Inc: Nova Biomedical Books 2009 pp251-283. Chen

2008

Yan BP, Ajani AE, New G, Duffy SJ, Farouque O, Shaw J, Sebastian M, Lew R, Brennan A, Adrianopoulos N, Reid C, Clark DJ; on behalf of Melbourne Interventional Group Investigators. Are drug-eluting stents indicated in large coronary arteries? Insights from a multi-centre percutaneous coronary intervention registry. Int J Cardiol 2008 August 14 [Epub ahead of print]

Nelson MR, Reid CM, Ames DA, Beilin LJ, Donnan GA, Gibbs P, Johnston CI, Krum H, Storey E, Tonkin A, Wolfe R, Woods R, McNeil JJ. Feasibility of conducting a primary prevention trial of low-dose aspirin for major adverse cardiovascular events in older people in Australia: results from the ASPirin in Reducing Events in the Elderly (ASPREE) pilot study. Med J Aust. 2008 Jul 21;189(2):105-9.

Joubert J, Joubert L, Reid C, Barton D, Cumming T, Mitchell P, House M, Heng R, Meadows G, Walterfang M, Pantelis C, Ames D, Davis S.  The positive effect of integrated care on depressive symptoms in stroke survivors.  Cerebrovasc Dis. 2008;26(2):199-205.

Walls HL, Peeters A, Reid CM, Liew D, McNeil JJ. Predicting the effectiveness of prevention: a role for epidemiological modeling.  J Prim Prev. 2008 Jul;29(4):295-305.

Yan BP, Duffy SJ, Clark DJ, Lefkovits J, Warren R, Gurvitch R, Lew R, Sebastian M, Brennan A, Andrianopoulos N, Reid CM, Ajani AE; Melbourne Interventional Group. Rates of stent thrombosis in bare-metal versus drug-eluting stents (from a large Australian multicenter registry). Am J Cardiol. 2008 Jun 15;101(12):1716-22.

Reid C, Nelson MR, Shiel L, Chew D, Connor G, DeLooze F. Australians at risk: management of cardiovascular risk factors in the REACH Registry. Heart Lung Circ. 2008 Apr;17(2):114-8.

Zomer E, de Ridder I, Kompa A, Komesaroff P, Gilbert RE, Krum H.  Effect of urotensin II on skin microvessel tone in diabetic patients without heart failure or essential hypertension.  Clin Exp Pharmacol Physiol 2008 May 23; [epub ahead of print]

Kompa AR, See F, Lewis DA, Adrahtas A, Cantwell DM, Wang BH, and Krum H. Long-term but not short-term p38MAPK inhibition improves cardiac function and reduces cardiac remodeling post-myocardial infarction. J Pharmacol Exp Ther. 2008 Jun; 325(3):741-50.

Krum H, Iyngkaran P.  The black dog and the weak heart: comorbid depression in the patient with heart failure.  J Card Fail 2008;14:465-466.

W Kemp, S Roberts, H Krum.  Increased circulating urotensin II in cirrhosis: potential implications in liver disease.  Peptides 2008;29:868-872.

Flannery G, Gehrig-Mills R, Billah B, Krum H.  Analysis of randomized controlled trials on the effect of magnitude of heart rate reduction on clinical outcomes in patients with systolic chronic heart failure receiving beta-blockers.  Am J Cardiol 2008;101:865-869.

Krum H.  Clinical investigations of statins in heart failure: ventricular functions and anti-remodeling.  Heart Failure Clinics 2008;4:177-186.

Phrommintikul A, Tran L, Kompa A, Wang B, Adrahtas A, Cantwell D, Kelly DJ, Krum H. Effects of a Rho kinase inhibitor on pressure overload induced cardiac hypertrophy and associated diastolic dysfunction. Am J Physiol Heart Circ Physiol. 2008 Apr;294(4):H1804-14.

Szollosi I, Thompson BR, Krum H, Kaye DM, Naughton MT.Impaired pulmonary diffusing capacity and hypoxia in heart failure correlates with central sleep apnea severity. Chest 2008;134(1):67-72.

Myles P, Smith J, Knight J, Cooper DJ, Silbert B, McNeil J, Esmore DS, Buxton B, Krum H, Forbes A, Tonkin A the ATACAS Trial Group.  Aspirin and Tranexamic Acid for Coronary Artery Surgery (ATACAS) Trial: Rationale and design.  Am Heart J 2008;155:224-30.

Kemp W, Roberts S, Komesaroff PA, Zomer E, Krum H.  Urotensin II in chronic liver disease: In vivo effect on vascular tone.  Scand J Gastroenterol.  2008;43:103-109.

Tobing D, French J, Varigos J, Meehan A, Billah B, Krum H for the post-MI audit group.  Do patients with heart failure appropriately undergo invasive procedures post-myocardial infarction?  Results from a prospective multicentre study.  Int Med J  2008; Apr 4 [epub ahead of print]

2007

Robinson PJ, Billah B, Leder K, Reid CM; ASCTS Database Committee. Factors associated with deep sternal wound infection and haemorrhage following cardiac surgery in Victoria. Interact Cardiovasc Thorac Surg. 2007 Apr;6(2):167-71.

Dart AM, Cameron JD, Gatzka CD, Willson K, Liang YL, Berry KL, Wing LM, Reid CM, Ryan P, Beilin LJ, Jennings GL, Johnston CI, McNeil JJ, Macdonald GJ, Morgan TO, West MJ, Kingwell BA. Similar effects of treatment on central and brachial blood pressures in older hypertensive subjects in the Second Australian National Blood Pressure Trial. Hypertension. 2007 Jun;49(6):1242-7.

Yan BP, Gurvitch R, Duffy SJ, Clark DJ, Sebastian M, New G, Warren R, Lefkovits J, Lew R, Brennan AL, Reid C, Andrianopoulos N, Ajani AE. An evaluation of octogenarians undergoing percutaneous coronary intervention from the Melbourne Interventional Group registry. Catheter Cardiovasc Interv. 2007 Dec 1;70(7):928-36.

Buchbinder R, March L, Lassere M, Briggs AM, Portek I, Reid C, Meehan A, Henderson L, Wengier L, van den Haak R. Effect of treatment with biological agents for arthritis in Australia: the Australian Rheumatology Association Database. Intern Med J. 2007 Sep;37(9):591-600.

Ajani AE, Yan BP, Clark DJ, Eccleston D, Walton A, Lew R, Meehan A, Brennan A, Reid C, Duffy SJ; Melbourne Interventional Group (MIG) Investigators.  Contemporary treatment of in-stent restenosis and the incidence of recurrent in-stent restenosis in the era of drug-eluting stents. Heart Lung Circ. 2007 Aug;16(4):269-73.

Szollosi I, Krum H, Kaye D, Naughton MT.  Sleep apnea in heart failure increases heart rate variability and sympathetic dominance.  Sleep 2007;30(11):1509-1514.

Wein L, Wein S, Haas SJ, Shaw J, Krum H.  Pharmacological venous thromboembolism prophylaxis in hospitalized medical patients.  Arch Intern Med 2007;167(14):1476-1486.

R Clarke, J Yallop, L Piterman, J Croucher, A Tonkin, S Stewart, H Krum on behalf of the CHAT study team.  Adherence, adaptation and acceptance of elderly chronic heart failure patients to receiving healthcare via telephone-monitoring.  Eur J Heart Fail 2007;9:1104-1111.

Kemp W, Krum H, Colman J, Bailey M, Yandle T, Richards M, Roberts S.  Urotensin II: a novel vasoactive mediator linked to chronic liver disease and portal hypertension.  Liver International 2007 Nov;27(9):1232-9.

Martin J, Krum H.  Statins and clinical outcomes in heart failure.  Clinical Science 2007;113:119-127.

Phrommintikul A, Haas SJ, Elsik M, Krum H.  Target haemoglobin concentrations in chronic kidney disease - Authors' reply. Lancet 2007;369:1516-1517.

Clark R, Eckert K, Stewart S, Phillips S, Yallop J, Tonkin A, Krum H.  Rural and urban differentials in primary care heart failure management: new data from the CASE study.  Med J Aust 2007;186:441-445.

Pepe S, Marasco SF, Haas SJ, Sheeran FL, Krum H, Rosenfeldt FL.  Coenzyme Q10 in cardiovascular disease.  Mitochondrion 2007;7S:S154-S167.

Krum H, Kemp W.  Therapeutic potential of blockade of the urotensin II system in systemic hypertension.  Curr Hypertens Rep 2007;Mar 9(1):53-58.

Rosenfeldt FL, Haas SJ, Krum H, Hadj A, Ng K, Leong J-Y, Watts GF.  Coenzyme Q10 in the treatment of hypertension: a meta-analysis of the clinical trials.  J Hum Hyper 2007;21:297-306.

Phrommintikul A, Haas SJ, Elsik M, Krum H.  Mortality and target haemoglobin concentrations in anaemic patients with chronic kidney disease treated with erythropoietin: a meta-analysis.  Lancet 2007;369:381-388.

Elsik M, Krum H.  Should beta blockers remain first-line drugs for hypertension?  Aust Prescriber 2007;30:18-21.

Haas SJ, Hill R, Krum H, Liew D, Tonkin A, Demos L, Stephan K, McNeil J.  Clozapine-associated myocarditis: a review of 116 cases of suspected myocarditis associated with the use of clozapine in Australia during 1993-2003.  Drug Safety 2007;30:47-57.

Kaye DM, Krum H.  Drug discovery for congestive heart failure: New era of pharmacological therapies or end of the pipeline?  Nature Rev Drug Discov 2007;6(2):127-139.

Krum H, Ashton E, Reid C, Kalff V, Rogers J, Amarena J, Singh B, Tonkin A.  Double-blind, randomized placebo-controlled, parallel-group, multicenter, phase III study to assess the impact of high-dose HMG CoA reductase inhibitor therapy on ventricular remodeling, pro-inflammatory cytokines and neurohormonal parameters in patients with chronic systolic heart failure.  J Card Fail. 2007;13:1-7.

Szramka M, Harriss L, Ninnio D, Windebank J, Brack J, Skiba M, Krum H. The effect of rapid lipid lowering with atorvastatin on autonomic parameters in patients with coronary artery disease. Int J Cardiol  2007;117:287-291.

Rogers SL, Magliano DJ, Levison DB, Webb K, Clarke PJ, Grobler MP, Liew D. A dose-specific meta-analysis of lipid changes in randomized controlled trials of atorvastatin and simvastatin.  Clin Ther. 2007 Feb;29(2):242-52.

2006

Yallop J, Chan B, Piterman L, Tonkin A, Forbes A, Davidson P, Clark R, Halcomb E, Nangle A, Stewart S, Croucher J, Krum H on behalf of the CHAT Study Group.  The Chronic Heart-failure Assistance by Telephone (CHAT) Study: Assessment of telephone support for vulnerable patients with chronic disease.  Asia Pacific Journal of Family Medicine 2006;5(2).

Ajani AE, Marwick TH, Krum H.  Aldosterone antagonists: a new treatment option for patients with post-myocardial infarction heart failure.  Cardiovasc Revascularization Medicine 2006;7:234-236.

Krum H, Jelinek M, Stewart S, Sindone A, Atherton J, Hawkes A, Foreman R. Guidelines for the prevention, detection and management of people with chronic heart failure in Australia 2006. Med J Aust  2006;185:549-56.

Zimmet H, Krum H. Beta-blockers for treatment of heart failure in the elderly. J Pharm Pract Res 2006;36:229-233.

Krum H, Cameron P.  Diuretics in the treatment of heart failure: Mainstay of therapy or potential hazard? Editorial Comment. J Card Fail. 2006;5:333-335.

Krum H, Meehan A, Varigos J, Loane P, Billah B.  Does presence of heart failure alter prescribing of drug therapy following myocardial infarction?  A multicentre study of Australian hospitals.  Med J Aust 2006;185:191-194.

Yallop J, Clark R, Chan B, Croucher J, Wilson A, Sellar B, Piterman L, Tonkin A, Krum H.  CHAT--a study of a nurse-led system of care.  Aust Nurs J 2006;14:19.

Dulin B, Krum H.  Drug therapy of chronic heart failure in the elderly: the current state of clinical-trial evidence.  Curr Opin Cardiol. 2006;21:393-399.

Aw T-J, Liew D, Tofler GH, Schneider HG, Morel-Kopp M-C, Billah B, Krum H.  Can the blood pressure effects of COX-2 selective inhibitors be explained by changes in plasma aldosterone levels?  J Hypertens 2006;24:1979-1984.

Krum H, Stewart S.  Chronic heart failure: time to recognise this major public health problem. Editorial.  Med J Aust 2006;184(4):147-148.

Ajani AE, Szto G, Duffy SJ, Eccleston D, Clark DJ, Lefkovits J, Chew DP, Warren R, Black A, New G, Walton A, Lew R, Shaw J, Horrigan M, Sebastian M, Yan BP, Brennan A, Meehan A, Reid C, Krum H.  The foundation and launch of the Melbourne Interventional Group: A Collaborative Interventional Cardiology Project.  Heart Lung and Circulation 2006;15:44-7.

Krum H, Aw J, Haas SJ, Liew D.  Blood Pressure Effects of COX-2 Inhibitors.  J Cardiovasc Pharmacol 2006;47[Suppl 1]:S43-S48.

Krum H, Lambert E, Windebank E, Campbell DJ, Esler M. Effect of angiotensin II receptor blockade on autonomic nervous system function in patients with essential hypertension. Am J Physiol Heart Circ Physiol. 2006;290:H1706-12.

Krum H.  Eplerenone.  (Letter to Editor)  Aust Prescriber 2006;29:32-33.

Clark RA, Yallop J, Wickett D, Krum H, Tonkin A, Stewart S. Nursing sans frontières: a three year case study of multistate registration to support nursing practice using information technology. Aust J Adv Nursing. 2006;24:39-45

Nelson MR, Reid CM, Ryan P, Willson K, Yelland L.Self-reported adherence with medication and cardiovascular disease outcomes in the Second Australian National Blood Pressure Study (ANBP2). Med J Aust. 2006 Nov 6;185(9):487-9.

Yan BP, Ajani AE, Duffy SJ, New G, Horrigan M, Szto G, Walton A, Eccleston D, Lefkovits J, Black A, Sebastian M, Brennan AL, Reid CM, Clark DJ. Use of drug-eluting stents in Victorian public hospitals.  Med J Aust. 2006 Oct 2;185(7):363-7.

Ahimastos AA, Lawler A, Reid CM, Blombery PA, Kingwell BA. Brief communication: ramipril markedly improves walking ability in patients with peripheral arterial disease: a randomized trial. Ann Intern Med. 2006 May 2;144(9):660-4. [Summary for patients in: Ann Intern Med. 2006 May 2;144(9):I24.]

Dart AM, Gatzka CD, Kingwell BA, Willson K, Cameron JD, Liang YL, Berry KL, Wing LM, Reid CM, Ryan P, Beilin LJ, Jennings GL, Johnston CI, McNeil JJ, Macdonald GJ, Morgan TO, West MJ. Brachial blood pressure but not carotid arterial waveforms predict cardiovascular events in elderly female hypertensives. Hypertension. 2006 Apr;47(4):785-90.

Ronaldson KJ, O'Shea JM, Boyd IW.  Risk factors for rhabdomyolysis with simvastatin and atorvastatin. Drug Saf. 2006;29(11):1061-7.

Liew D, Lim SS, Bertram M, McNeil JJ, Vos T.  A model for undertaking effectiveness and cost-effectiveness analyses of primary preventive strategies in cardiovascular disease. Eur J Cardiovasc Prev Rehabil. 2006 Aug;13(4):515-22.